O'Brien P, Gozzo J J, Monaco A P
J Urol. 1980 Dec;124(6):802-3. doi: 10.1016/s0022-5347(17)55671-2.
Urine specimens from normal individuals, and from patients with bladder cancer, bladder papillomas and urinary tract infections were assayed for the presence of bladder tumor-related antigens. Ten-fold concentrated urine specimens were reacted in Ouchterlony gel diffusion against various anti-human monospecific antisera. With these antisera urine specimens from normal individuals were distinguished from those from patients with bladder carcinoma as well as bladder papilloma. However, the urine samples from individuals with urinary tract infections showed significant reactivity with many of the monospecific antisera as did specimens from patients with bladder cancer and bladder papilloma. Thus, investigations involved in the assay of bladder cancer biological markers should take the proteinuria associated with urinary tract infection into consideration. The potential importance of detecting tumor-specific components for early diagnosis and treatment of bladder neoplasms is stressed.
对正常个体以及患有膀胱癌、膀胱乳头状瘤和尿路感染患者的尿液样本进行膀胱肿瘤相关抗原检测。将浓缩10倍的尿液样本在双向琼脂扩散试验中与各种抗人单特异性抗血清反应。利用这些抗血清可区分正常个体的尿液样本与膀胱癌及膀胱乳头状瘤患者的尿液样本。然而,尿路感染患者的尿液样本与许多单特异性抗血清呈现出显著反应,膀胱癌和膀胱乳头状瘤患者的样本也是如此。因此,在检测膀胱癌生物标志物的研究中应考虑与尿路感染相关的蛋白尿。强调了检测肿瘤特异性成分对膀胱癌早期诊断和治疗的潜在重要性。